Visual acuity, oncologic, and toxicity outcomes with 103Pd vs. 125I plaque treatment for choroidal melanoma.
Sign Up to like & getrecommendations! Published in 2017 at "Brachytherapy"
DOI: 10.1016/j.brachy.2017.01.012
Abstract: PURPOSE To evaluate outcomes of choroidal melanoma patients treated with 125I or 103Pd plaque brachytherapy. METHODS AND MATERIALS From 1993 to 2012, our institution treated 160 patients with 103Pd (56.1%) and 125 patients with 125I… read more here.
Keywords: 125i plaque; choroidal melanoma; visual acuity; 103pd 125i ... See more keywords